eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current issue Archive Manuscripts accepted About the journal Editorial board Journal's reviewers Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
vol. 25

Original paper
Correlation of serotypes, molecular and biological characteristics of Chlamydia trachomatis and clinical manifestations of Chlamydia infection

Dmitry F. Khvorik
Vladimir M. Tsyrkunov
Svetlana A. Kostiuk

Post Dermatol Alergol 2008; XXV, 6: 247–254
Online publish date: 2009/01/12
Article file
- correlation.pdf  [0.09 MB]
Get citation
JabRef, Mendeley
Papers, Reference Manager, RefWorks, Zotero

Causative agents of Chlamydia infections belong to the Chlamydiaceae family, Chlamydia genus. Within this genus are recognized four types of chlamydiae, i.e. C. trachomatis, C. psittaci, C. pneumoniae and C. pecorum [1]. Antigenic properties of chlamydiae are preconditioned by the interior membrane represented by liposaccharides. Outer membrane proteins (OMP) are integrated into it. Major outer membrane protein (MOMP) is known to comprise 60% of the general protein content. The rest of the antigen structure is represented by type 2 proteins of the outer membrane (OMP-2). The presence of a general bulk genus-specific antigen enables the Chlamydia infection to be diagnosed by means of the immune fluorescent method based on the level of specific antibodies in it. The genus-specific antigen is known to be different in all species of chlamydiae. It contains more than 18 different components. Its size in C. trachomatis is 155 kDa and it contains epitopes in protein of 40 kDa, the hsp-60 protein of thermal shock. The type-specific antigen is known to be different for serovars of C. trachomatis, and contains epitopes in 40 kDa, the MOMP protein, the 30 kDa protein in A and B serotypes [2, 3]. Eighteen antigenic variants (serotypes) of C. trachomatis have been differentiated and classified into three groups. Group I consists of causative agents of trachoma (serotypes A, B, Ba, C). Its carriers are known to be insects. The main way to get infected is to rub in the agent into the mucous coat of the eye. Group II (present only in man) comprises causative agents of urogenital clamidiosis (serotypes D, E, F, G, H, I, J, K). In cases of urogenital clamidiosis (UGC) the infection enters the body during sexual intercourse (sexual clamidiosis). Rare cases of this infection can occur when rubbing in the agent with dirty hands into the mucous membrane of the eye. Pneumonia of newborns caused by C. trachomatis occurs as the result of infection of the newborn with Chlamydia from the mother during birth. Group III (serotypes L1, L2, L3) comprises causative agents of tropical venereal lymphogranuloma. Serotypes of venereal lymphogranulomatosis spread through the lymphatic system, infecting macrophages and epithelial cells. The main ways to get infected with C. trachomatis are sexual, vertical and everyday regular contacts. Haematogenous way of spread of the infection is characteristic for serotypes D and K of C. trachomatis, associated with systemic rheumatoid diseases [1]. Besides, it has been established that H and L2/434/BU C. trachomatis types can infect the endothelial cells of human veins and stimulate expression of tissue factor that reaches its maximum 18 hours following infection. From 60 to 80% of all strains belong to serotypes D, E and F, with minor variations in various parts of the world [4, 5]. The serotype is capable of defining the infectious nature of a causative agent, which can be measured by the number of inclusion-forming units (IFU) of Chlamydia in clinical samples. It has been proven that sex, age and race of patients as well as their infection can be connected with a definite type of C. trachomatis and associated with the number of IFU. Samples with strains of B group tended to have a larger number of IFU than samples with strains of group C [5]. In female organisms the IFU index is higher than in male organisms. Ageing causes a decrease of this index. It has been shown that persistence of the causative agent in the human organism is connected with serotype of group C [2]. Within the course of evaluation of dependence of the character of clinical pathology on the serotype of the causative agent it has been established that the rate of development of endocervicitis and bleeding in females with Chlamydia infection does not depend on the variant of serotype, while in males with a small number of polymorphonuclear leucocytes in urethral scrapings the probability of diagnosis of serotype F or G was rather high. Serotype variant F was found in women from San Francisco in the background of the presence of inflammation of pelvic organs [4]. In other clinical studies males with the symptoms of clamidiosis demonstrated a rather high probability of selection of serotype variant Da, in contrast to females, in whom serotype variant K had been isolated [4, 5].
This study aimed to establish the correlation between serotypes, molecular and biological characteristics of and various clinical manifestations of Chlamydia infection.
Material and methods
Forty two patients (18 females and 24 males), aged 17-44, who applied for medical aid at the Department for Prevention of Sexually Transmitted Infections attached to the Grodno Regional Dispensary for Skin and Venereal Diseases, Belarus, underwent complex clinical and microbiological examination. All the above patients were divided into several groups depending on the types of isolated serotypes of C. trachomatis, concentration of DNA of C. trachomatis, variant of the infection (monovalent/polyvalent infection), stability/sensibility to antibiotics and the prevailing clinical variant of Chlamydia infection (localization of inflammatory process, complications).
Verification of aetiological diagnosis
The diagnosis of Chlamydia infection was made on the basis of anamnesis, clinical signs, results of aetiological verification, i.e. search for IgA, IgG, IgM class antibodies to antigens of C. trachomatis by method of immune-enzyme analysis (IEA), and isolation of Chlamydia from scrapings obtained from the cervical canal and urethra by the method of direct reaction of immune fluorescence (DIF). In the case of positive IEA and DIF the material was studied by means of PCR (quantitative analysis). Patients with 100% positive PCR results were included in the study. Aetiological decoding of mixed infection was performed using routine methods, i.e. in cases of ureaplasmosis and mycoplasmosis we applied DIF and culture method (inoculation onto the IST medium with further evaluation of antibiotic resistance); in cases of candidosis and gardnerellosis by means of bacterioscopic analysis of Gram-stained smears; and in cases of trichomoniasis by means of bacterioscopic evaluation of smears stained with 1% solution of methylene blue. Quantitative analysis of DNA of Chlamydia trachomatis To quantitatively evaluate specific ompA fragments of a C. trachomatis gene, coding the main MOMP surface protein, we performed PCR in a real-time mode (Rotor-Gene 3000, Australia) with application of species-specific primers and TaqMan oligonucleotide tests. Standardization of the study was made against the NAGK one-copy human gene. Successions of primers, probes and conditions of amplification for quantitative evaluation of the NAGK human gene were adapted from the work by Gotoh et al. (2005) [6, 7].
Serotyping of Chlamydia trachomatis
In order to define serotypes of C. trachomatis 42 samples of DNA, isolated from 42 C. trachomatis-positive samples of biological material (scrapings of epithelial cells from the urogenital tract) amplified and purified in Centricon-100, underwent PCR sequencing with application of couples of primers for detection of variable domains (VDI-VDIV) of the omp1 gene. Due to the existing differences in nucleotide sequences of variable domains of the omp1 gene among these or those serovars the below pairs of primers were applied in genotyping of isolates of C. trachomatis: C. trachomatis 1 – 5´ATGAAAAAACTCTTGAAATCGG–3´ (forward-primer P1); C. trachomatis 2 – 5´ACTGTAACTGCGTATTTGTCTG–3´ (reverse-primer OMP2), enabling detection of the fragment of 1 C. trachomatis gene of ~1130 p.n. omp in length, containing all the four variable domains (VDI-VDIV); C. trachomatis 1 – 5´ATGAAAAAACTCTTGAAATCGG–3´ (forward-primer P1); C. trachomatis 2 – 5´CTTGKAYTTTAGGTTTAGATTGAGC–3´ (reverse-primer CT6R), enabling detection of the fragment of 1 C. trachomatis gene of ~675 p.n. omp in length, containing two variable domains (VDI, VDII); C. trachomatis 1 – 5´GCTCAATCTAAACCTAAARTMCAAG–3´ (forward-primer CT6F); C. trachomatis 2 – 5´ACTGTAACTGCGTATTTGTCTG–3´ (reverse-primer OMP2), enabling detection of the fragment of 1 C. trachomatis gene of ~481 p.n. omp in length, containing two variable domains (VDIII, VDIV); C. trachomatis 1 – 5´TGGGATCGYTTTGATGTATT–3´ (forward-primer NL-F); C. trachomatis 2 – 5´CCAATGTARGGAGTGAACAT–3´ (reverse-primer NL-R), enabling detection of the fragment of 1 C. trachomatis gene of ~481 p.n. omp in length, containing two variable domains (VDII, VDIII). Out of C. trachomatis-positive samples all 42 samples were successfully amplified with application of P1-OMP2 primers, the interior pair of NL-F – NL-R primers and CT6F-OMP2 as well as P1-CT6R primers for semi-cluster PCR. For each reaction of amplification we added 10 P1-OMP2 of DNA matrix to the PCR mixture (the final volume of the reaction comprised 50 µl), containing PCR-buffer (10 mM Tris-HCL, 50 mM KCl, pH 8,3, 2,0 mM MgCl2), 200 mM MgCl2 of each deoxynucleotide triphosphate, Taq polymerase. Primers were added in the following amounts (Table 1). The amplification programme was designed in the following way: 94°C – 10 min (initiation of reaction), 94°C – 30 s (melting), 50°C – 30 s (curing), 72°C – 2 min (elongation), 72°C – 7 min (additional time of elongation of elongation at the end of the reaction). The amplified fragments were visualized by electrophoresis in 1% agarose gel containing ethidium bromide. Electrophoregram of each 42 samples had 4 specific fragments, i.e. P1/OMP2, P1/CT6R, CT6F/OMP2 and NL-F/NL-R. The length of the P1/OMP2 fragment was represented by 1124 pairs of nucleotides (p.n.) in 28 samples and by 1114 p.n. in 14 samples; the length of the P1/CT6R fragment by 670 p.n. in 28 samples as well as by 679 p.n. in 14 samples; the length of the CT6F/OMP2 fragment in 28 samples by 479 p.n., in 14 samples by 480 p.n.; the length of the NL-F/NL-R fragment in all 42 samples was represented by 482 p.n. PCR amplicons were purified using the BigDye XTerminator Purification kit and underwent sequencing (with further electrophoresis using the ABI Prism 310 genetic analyzer) using pairs of P1/OMP2, P1/CT6R, CT6F/OMP2, NL-F/NL-R primers and the following mode of operation: 96°C – 20 s – 30 cycles (melting), 50°C – 20 s (annealing), 60°C – 4 min (elongation), 40 cycles 4°C (incubation). To increase the liability of the reaction the amplicons were sequenced in two directions. The information on all the nucleotide sequences was combined into one sequence with about 863 pairs of nucleotides, comprising 4 omp1 variable domains. This sequence comprised 73% of the total length of the C. trachomatis omp1 gene. Data on the nucleotide sequences of samples were considered with application of the (www.ncbi.nlm.nlm.nih.gov/blast/bl2seq/bl2.html) nucleotide-nucleotide BLAST search engine for identification of attribution of this or that sequence to a definite serotype. Nucleotide sequences omp1 of genes of standard samples of all 15 serotypes (A-L3) were obtained from the GenBank database, i.e. A/Har-13 (J03813), A/Sa1/OT (M58938), B/Alpha-95 (U80075), B-Jali-20 (M33636), B/TW-5/OT (M17342), BaApache-2 (AF063194), C/TW3 (AF202455), C/TW3/OT (M17343), C/TW-3/OT (AF352789), D/B120 (X62918), D/B185 (X62919), D/IC-Cal8 (X62920), E/Bour-1990 (X52557), E/Bour-1997 (U78763), F/IC-Cal (X52080), G/UW57/Cx (AF063199), H/Wash (X16007), I/UW-12 (AF063200), J/UW36/Cx (AF063202), K/UW31/Cx (AF063204), L1/440-Bu (M36533), L2/434-Bu (M14738), L3/404-Bu (X55700), MoPn (M64171). The sequencing analysis software module was applied to analyze the data on sequencing of DNA. The software processed the obtained data with application of multi-component analysis, by means of deducting the base line and scaling. Having processed the data the software could detect the peaks and define the sequence of the bases. Software for evaluation of data on sequencing was connected with the DataUtility software which could perform the following two functions: creation of matrices for their further application in computer software for accumulation and evaluation of the data as well as noise level control. The use of the program package enabled us to show the results of the experiment on the computer display (i.e. electrophoregrams, data processed in the form of tables and diagrams or a combination of electrophoretic data and corresponding diagrams).
Sequence analysis of the region comprising VDI-VDIV showed that 15 samples of patients under study belonged to serotype K with 95% compliance with the sequence of K/UW31/Cx gene variant, and 23 samples were attributed to serotype D. In the case of 9 samples compliance with the sequence of D/B185 (X62919) gene variant comprised 95% while in 3 samples compliance with the sequence of the D/B185 (X62919) gene variant equalled 94%; 11 samples demonstrated 95% compliance with the sequence of the D/B120 (X62918) gene variant and 4 samples complied with serotype C with 95% compliance with the sequence of the C/TW-3/OT (AF352789) gene variant. Studies of sequences of nucleotides of 42 PCR-positive samples, conducted with application of the BLAST computer software, demonstrated the predominant prevalence of C. trachomatis genotype of serotype D (n=23, 54.8%) over serotype K (n=15, 37.7%) and C (n=4, 9.5%). In this case various nucleotide changes in the fragment of omp1 gene under study could be observed (Table 2). It should be mentioned that 19 isolates, isolated from the biological material and identified as serotype D, had 2 different nucleotides of D/B185 or D/B120 omp1 in positions 574 and 843, while 4 samples tended to have an additional nucleotide change in position 1042. At the same time, 15 isolates, identified as serovar K, had two different nucleotides of K/UW31/Cx omp1 gene in positions 503 and 628, while 4 isolates, identified as serovar C, had 4 different nucleotides of C/TW-3/OT omp1 gene in positions 569, 571, 972 or 1003. Thus, within the territory of the Republic of Belarus under study we observed the prevalent occurrence of serotypes D, K and C of C. trachomatis in the biological material of patients with chronic inflammatory diseases of the urogenital tract. Variant D (54.7%) serotype turned out to be the prevailing one; variant K (35.7%) is a less frequent phenomenon, while variant C (9.6%) turned out to be the least frequent one. At the same time we registered a 94-95% homology with standard cultures of D/B120 (X62918), D/B 185 (X62919), K/UW31/Cx (AF063204). Below a comparison of the character of clinical manifestations of Chlamydia infection and topical diagnosis in patients with different serotypes of the causative agent is shown. Table 3 shows the distribution of patients under study depending on serotype and prevailing pathology. Table 3 confirms that the group of patients with the diagnosed serotype C of C. trachomatis presents the greatest deal of interest. In spite of the small number of patients in this study group both females and males tended to have complications of the Chlamydia infection in the form of arthropathic kind of chlamidiosis (Reiter’s syndrome) or sterility. It is very important to take this fact into account in the prognostic aspect of patients’ condition. There were fewer such patients in the study group of subjects with D and serotypes of C. trachomatis. On the other hand not a single patient with serotype D of C. trachomatis had an arthropathic form of infection (Reiter’ syndrome), which is also very important to take into account when making the prognosis of the development of potential complications. The incidence of such complications as sterility in the groups under comparison was not equal, i.e. it ranged from 13.3% in patients with serotype K of C. trachomatis, and 26.0% with serotype D of C. trachomatis, up to 50% in patients with serotype C of C. trachomatis. Also, the average history of the disease in patients with serotype C of C. trachomatis tended to be much higher than in patients with serotypes K and D of C. trachomatis. The clinical presentation was represented by various kinds of pathology. Male patients with three serotypes of C. trachomatis tended to predominantly have urethritis and prostatitis. The incidence of this pathology in patients with serotype K of C. trachomatis turned out to be much higher than in other study groups. Female patients with serotype D of C. trachomatis tended to suffer from endocervicitis more frequently than patients with other serotypes. Sterility was diagnosed in females of all study groups but the ones with serotype C of C. trachomatis displayed a 100% incidence rate; in patients with serotype K, 2 of 3 patients suffered from this pathology; in subjects with serotype D (D/B120 (X62918) 3 out of 6 patients had this problem. We have established before that patients with Chlamydia infection had a wide range of fluctuation in C. trachomatis DNA concentration. That fluctuation tended to depend upon various factors, i.e. from the conditionally low level (up to 1.0 × 104 copies/ml) to the medium (1.1 × 104 to 2.0 × 105) and the high one (more than 2.1 × 105 copies/ml). At the same time the average concentration of DNA C. trachomatis (without taking into account the nature of the pathology and localization of the inflammatory process) comprised 1.5 ± 0.2 × 105 copies/ml in males and 4.3 ± 0.5 × 104 copies/ml in females [2]. In this respect we have compared the data on DNA concentrations depending on serotypes of C. trachomatis. The data obtained are shown in Table 4. Table 4 shows that the lowest concentrations of DNA in both female and male patients were observed in subjects with genotype C, which correlated with the previously obtained data on the low level of DNA in patients with complicated forms of chronic infection [1, 2]. The highest concentrations were registered in males with serotype D (higher than in females). Also, a higher level of DNA was observed in males with serotype K; this index was twice as high as in females. Isolation of other sexually-transmitted causative agents (mixed infections) in patients with Chlamydia infection served as the reason for studies of dependence of the variant of the infection (mono-, mixed) on the kind of serotype. The results obtained are shown in Table 5. Chlamydia as the only aetiological agent was revealed in only 10 patients (23.8%) under study. Mixed infection agents were Ureaplasma (28.6%), Candida (16.7%), Mycoplasma (14.3%), other fungi (11.9%), Gardnerella (4.8%). Table 5 shows that irrespective of serotype and its variants no predominance of Chlamydia infection in the form of mono-infection (23.8%) was revealed. All patients under study with serotype C had Chlamydia accompanied by fungi of the Candida family. This causative agent rarely occurred in patients with serotype D and was not found in patients with serotype K. Female patients with serotype D tended to predominantly have mycosis. Ureaplasmas were more frequently observed in males and females with serotype K as compared to the subjects in other study groups. A high rate of C. trachomatis resistance to antibiotics (poly-resistance) in chronic Chlamydia infection has been registered before [2]. The basic initial medicines prescribed in such cases are tetracyclines and macrolides. We studied the rate of C. trachomatis resistance to antibiotics in cases of administration of the above drugs depending on the variant of a serotype of a causative agent. These data are shown in Table 6. Table 6 shows that C. trachomatis in all patients with serotype C demonstrated a 100% simultaneous resistance to both tetracyclines and macrolides. Keeping in mind that all of those patients had complicated forms of the infection, one can come up with an explanation of this fact. A similar situation was observed in patients with serotype K, in whom all the isolated cultures of C. trachomatis demonstrated resistance to the antibiotics under study. By analogy with the group of patients with serotype C this group comprised patients with aggravated forms (arthropathic variant and sterility) that correlated with the already existing data on the predominant persistence of the causative agent connected with serotype C [2].
Based on the conducted studies the prevailing spread of serotypes D (54.7%), K (35.7%) and C (9.6%) has been determined in the biological material of the patients with chronic inflammatory diseases of the urogenital tract. At the same time in 94-95% of cases homology with standard D/B120 (X62918), D/B185 (X62919), K/UW31/Cx (AF063204) cultures has been observed. It has also been determined that 19 isolates, identified as serotype D, tended to display a difference in two nucleotides of D/B185 or D/B120 omp1 gene in position 574 and 843, while 4 samples tended to have an additional nucleotide change in position 1042. As for serotype K, nucleotide changes of K/UW31/Cx omp1 gene in positions 503 and 628 have been observed. However, the largest number of nucleotide substitutions in this study was characteristic for serotype C, which displayed a difference in C/TW-3/OT omp1 gene concerning 4 nucleotides in positions 569, 571, 972 and 1003. Comparative analysis of serologic variants of the causative agent and clinical manifestations showed that the most frequent causes of inflammatory processes of the urogenital tract are associated with serotypes D and K of C. trachomatis, which cause development of urethritis, adnexitis, endocervicitis and other kinds of pathology. One can observe an associative connection between development of complicated forms of Chlamydia infection in the form of arthropathic forms and sterility and C and K C. trachomatis serotypes. These two sero-variants of C. trachomatis tend to have a higher degree of resistance to antibiotics, which can serve as one of the reasons for development of complications of Chlamydia infection in the form of arthropathic pathology (Reiter’s syndrome) and sterility in women.
1. Semionov VM. Khlamidiynaya infektsiya (Chlamydia infection)/Semionov VM, Semionov DM, Khvorik DF, et al. Vitebskiy Gosudartstvenniy Meditsinskiy Universitet. Vitebsk 2005; 206. 2. Dean D. Recombination in the genome of Chlamydia trachomatis involving the polymorphic membrane protein C gene relative to omp A and evidence for horizontal gene transfer. J Bacteriol 2004; 186: 4295-306. 3. Frost SD. Using sexual affiliation networks to describe the sexual structure of a population. Sex Transm Infect 2007; 83 Suppl 1: 137-42. 4. Morre SA, Lyons JM. Murine models of Chlamydia trachomatis genital tract infection: use of mouse pneumonitis strain versus human strains. Infect Immun 2000; 68: 7209-11. 5. Morre SA, Moes RI, van Valkengoed JP, et al. Genotyping of Chlamydia trachomatis in urine specimens will facilitate large epidemiological studies. J Clin Microbiol 1998; 36: 3077-8. 6. Kostiuk SA, Kulaga OK, Poluyan OS. Kliniko-laboratornanya harakteristika vospalitelnykh processov reproduktivnykh organov, obuslovlennykh assotsiatsiyey vozbuditeley (Clinical and laboratory characteristics of inflammatory processes of reproductive organs preconditioned by association of causative agents)/Kostiuk SA. Virusniye infektsii: epidemiologiya, klinika, laboratornaya diagnostika i profilaktika. Mat. Mezhd. Konf. 29–30 noyabria 2007. Red. Prof. L.P. Titov. Minsk 2007; 180-183. 7. Kostiuk SA. Noviye aspekty klinicheskogo primeneniya polimeraznoy reaktsii (New aspects of clinical application of polymerase chain reaction)/Kostiuk SA, Kulaga OK, Khvorik DF. Meditsinskiye Novosti 2006; 5: 14-18. 8. Persson K. The role of serology, antibiotic susceptibility testing and serovar determination in genital chlamydial infections. Best Pract Res Clin Obstet Gynaecol 2002; 16: 801-14. 8. Persson K. The role of serology, antibiotic susceptibility testing and serovar determination in genital chlamydial infections. Best Pract Res Clin Obstet Gynaecol 2002; 16: 801-14.
Copyright: © 2009 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Quick links
© 2020 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe